[Influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis].
OBJECTIVE
To observe the influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis.


METHODS
A total of 54 patients with endometriosis and without medical complications were random selected. Xianglingwan was administered from the fifth day of the menstrual cycle for 3 weeks every month as a therapeutic course, and three months for a therapeutic period. Pelvic type B ultrasonograph and blood CA125 were detected before and after treatment. Visual analogue scale was admitted to evaluate the dysmenorrhea.


RESULTS
The serum CA125 reduced obviously after therapy. There was a significant difference between them (P < 0.01). The symptom of dysmenorrhea also reduced obviously after treatment. There was a significant difference between them (P < 0.05).


CONCLUSIONS
Xianglingwan can treat edometriosis effectively, and has less adverse reactions, it can also reduce the symptom of dysmenorrheal and the serum CA125.
Affiliated Obsretrics and Gynecology Hospital, College of Medicine, Zhejiang University, Hangzhou 310006, China.
Chun-Bo
CB
Yang
Yi
Y
Chen
Hang-Mei
HM
Jin
Wei-Wen
WW
Ying
D000328:Adult; D018394:CA-125 Antigen / Q000097:blood*; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D004412:Dysmenorrhea / Q000097:blood* / Q000188:drug therapy*; D004715:Endometriosis / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans
D018394:CA-125 Antigen; D004365:Drugs, Chinese Herbal